All In Biotech

Drug Trial Radar · NCT07249788

Resmiterom Efficacy & Safety in Patients With MASH

Clinical Evaluation of Safety and Efficacy of Resmiterom in Patients With MASH (Metabolic Dysfunction-Associated Steato-Hepatitis) A Prospective, Open-label, Interventional Study

Last checked: Nov 20, 2026Latest source record: Dec 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

165

Planned (sponsor's estimate)

Start

Oct 17, 2025

Primary completion

Oct 16, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Nabiqasim Industries (Pvt) LtdIndustry
Sponsor type
Industry
First posted
Nov 25, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 4 clinical trial study aims to further evaluate the safety and therapeutic efficacy of Resmetirom in Pakistani patients with fibroscan proven MASH.

Conditions

  • MASH - Metabolic Dysfunction-Associated Steatohepatitis

Interventions

  • ResmetiromDrug

    1st FDA approved MASH therapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. FIB-4 and CAP score/LSM on fibroscanTime frame: 6 months
  2. Changes in thyroid profileTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Liver transplant center, Holy family hospital

    Rawalpindi, Punjab Province, Pakistan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.